Putting a plastic surgery practice for sale in 2026 means selling into a market that looks very different from five years ago. Private equity platforms that barely existed a few years ago are now among the most active buyers. Some of those same platforms are approaching the point where their own investors want to sell. And patient demand, after a few uneven years, is growing again.
This guide explains what that means for a surgeon-owner. It covers how consolidation has reshaped the market, why a wave of platform sales may be coming, what it means for your timing and price, how to present your practice, and whether listing it publicly is ever a good idea. There’s a short section at the end for surgeons looking to buy.
Key takeaways
- Consolidation is well underway. Physician Growth Partners counts ten or more PE-backed plastic surgery platforms, six of them formed in a single 24-month period (PGP).
- Private equity firms typically hold companies for several years. The median US hold reached 3.4 years at the end of 2024, the longest in nine years (PitchBook).
- Platforms preparing to sell often buy add-ons to grow first, which can mean strong demand for independent practices.
- Confidential, targeted outreach usually beats a public listing for a plastic surgery practice for sale.
What does it mean to put a plastic surgery practice for sale?
It means offering your practice, meaning its patient base, brand, team, equipment, contracts, cash flow and often its surgical facility, to a buyer, usually while you stay on to operate for a transition period. Most sales today are private, run through a confidential process rather than a public listing.
The practice you’re selling has several parts buyers may price separately: the clinical practice, any accredited surgical facility, the real estate if you own it, and non-surgical services like injectables and skin care. Deciding early which parts are included, and how, shapes which buyers are interested and what they’ll pay.
How has plastic surgery consolidation changed the market?
Private equity-backed platforms have become major buyers, creating competition for well-run practices that used to sell only to other surgeons. The market is still fragmented, with most practices independent, but the number of groups trying to consolidate it has more than doubled in a short time.
Physician Growth Partners lists platforms including Prime Plastic Surgery, Ascend Plastic Surgery Partners, Athenix, Inspire Aesthetics and Olympus Cosmetic Group, and noted six new platforms formed over a 24-month span. FOCUS Investment Banking reported a 440% increase in plastic surgery deal volume over the two years to 2024.
Plastic surgery is following a path other specialties are already on. Dermatology and ophthalmology have seen significant private equity activity, according to the Milbank Memorial Fund. The usual private equity pattern is for platforms to grow, then sell to larger investors as consolidation deepens. It’s a useful preview, not a prediction.
What is the platform exit wave?
It’s the point when private equity firms that bought plastic surgery platforms in recent years look to sell them, usually to larger investors or other strategic buyers. Because private equity funds hold investments for a limited period, a group of platforms formed around the same time tends to reach its exit window around the same time.
The timing follows from how private equity works. FOCUS describes a five-to-seven-year hold period in physician practice underwriting. PitchBook found that more than 30% of US PE-backed companies had been held for at least five years by the end of 2024, the highest share in nearly a decade. Several plastic surgery platforms formed in the early 2020s, so the earliest are approaching that window.
We call this a coming wave, not a certainty. Sponsors can extend holds, recapitalize or sell pieces of a business. But for surgeons, the direction matters more than the exact date.
What does the platform exit wave mean if you’re selling?
Mostly opportunity. Sponsors preparing to sell often buy add-ons first to grow earnings and show momentum, which can create strong demand for independent practices. New sponsors that buy existing platforms also tend to keep acquiring. The main risk is joining a platform late in its hold, when the next sale is close.
There are three practical effects:
- More competition for good practices. Platforms want to show growth before a sale, and adding a well-run practice is the fastest way.
- Timing questions for rollover equity. If you roll equity into a platform about to be sold, your second payday may come quickly, but at a price you don’t control. If you join a new platform, you may wait longer for a potentially larger outcome.
- New buyers entering. When larger investors buy platforms, they often bring fresh capital and fresh acquisition targets.
Surgeons who already sold and rolled equity face their own version of this question. Our guide to plastic surgery rollover equity covers what happens to your stake when a platform is sold.
7 moves to make before your plastic surgery practice is for sale
1. Decide what you’re selling
Clinical practice only, or with your surgical facility, your real estate and your non-surgical services? Each choice changes the buyer pool and the price.
2. Recast your financials
Buyers price on adjusted EBITDA. Have an advisor recast three years of numbers, including your post-sale compensation, before any buyer sees them. Our guide to plastic surgery practice valuation walks through a worked example.
3. Tighten your practice management
Buyers review the metrics that show how well the practice runs: consultation volume, conversion rates, case mix, average revenue per procedure, marketing cost per new patient and staff turnover. Good plastic surgery practice management shows up directly in your price.
4. Reduce dependence on yourself
An associate surgeon, a strong practice manager and a practice brand beyond your name all lower the risk a buyer sees. FOCUS lists single-surgeon concentration of 70% or more of revenue as a factor that compresses valuations.
5. Clean up contracts and compliance
Gather facility accreditation reports, malpractice history, leases, equipment financing, employment agreements and marketing and photo-consent policies. Fix what you can before diligence.
6. Understand your state’s rules
Corporate practice of medicine laws affect how buyers can structure a deal. DLA Piper notes enforcement increased in 2026, including California settlements and a new Vermont law. Ask counsel how your state’s rules shape your options.
7. Choose your process
Decide whether to approach a few buyers quietly or run a broader competitive process. Either way, require NDAs and share information in stages.
How do you present a plastic surgery practice for sale?
Through a confidential summary first, then a detailed information memorandum shared only after a buyer signs an NDA. The goal is to tell a clear story: what makes the practice valuable, how it runs without you, and where it can grow. Buyers read hundreds of these, so clarity beats polish.
A strong information memorandum for a plastic surgery practice for sale usually covers:
- The practice’s history, locations, surgeons and team
- Services and revenue mix, surgical and non-surgical
- Three years of recast financials, with add-backs explained
- Consultation, conversion and case volume trends
- The surgical facility, its accreditation and equipment
- Marketing channels, brand strength and online reputation
- Growth opportunities a buyer could pursue
- What you want from the deal, including your role after closing
Leave out anything that identifies patients, and hold back sensitive details like staff pay until later stages.
Should you list your cosmetic surgery practice for sale publicly?
Usually not. Public listings on business-for-sale sites reach mostly unqualified buyers, and they risk tipping off staff, patients and competitors. A confidential approach to qualified surgeons, platforms and groups, with NDAs signed before your name is shared, generally produces better offers and protects your practice.
There are exceptions. A very small practice, or one in a market where no platform is active, may benefit from wider exposure to individual surgeons. Even then, a blind listing that hides your name and location is safer than a public announcement. Once staff hear rumors, some will start looking for other jobs, and that can lower your value during the sale itself.
How long does a plastic surgery practice sale take?
It varies. Preparation, such as recasting financials, adding surgeon capacity and cleaning up records, can take a year or more. The marketed process and diligence usually add several months. Practices that start early can time the sale to favorable market conditions rather than reacting to a buyer’s schedule.
The platform exit wave adds a timing layer. Platforms preparing for their own sale may move quickly on add-ons, while a new sponsor might take a few months to settle in before buying. An advisor who knows which platforms are active in your region can help you time outreach.
Is now the right time to sell?
Only you can answer that, but the market conditions are favorable for well-prepared practices. Demand is growing, with the American Society of Plastic Surgeons reporting cosmetic surgical procedures up 7% in 2025, and buyers are active. The better question is whether your practice, and your personal plans, are ready.
A useful test: if a strong offer arrived tomorrow, would you know what your practice is worth, what role you’d want afterward and what terms you’d refuse? If not, start there. Preparation costs little and keeps every option open, whether you sell next year or in ten.
What could slow plastic surgery consolidation?
Several things could: tighter state rules on corporate ownership of practices, higher borrowing costs that make acquisitions more expensive, a pullback in elective cosmetic spending during an economic downturn, and limits on physician non-competes. None seems likely to stop consolidation, but each can change prices and deal terms.
Cosmetic surgery is mostly discretionary and cash-pay, which makes it more sensitive to consumer confidence than insurance-based specialties. That cuts both ways: buyers value the cash economics, but they also stress-test your numbers against a slower year. Regulatory change matters too. DLA Piper describes growing enforcement of corporate practice rules in 2026, and states continue to limit physician non-competes, according to the American Medical Association. Expect buyers to structure deals conservatively as a result.
What happens to your team and patients after a sale?
Most buyers keep clinical and front-desk staff, because patients know them and they’re hard to replace. Back-office work like billing and marketing may move to the buyer’s shared services. Patients usually notice little at first, especially if you keep operating, which is one reason buyers want you to stay.
What are plastic surgery practices selling for?
Most sell for a multiple of adjusted EBITDA. FOCUS Investment Banking reported 2026 platform deals at 5x to 6x EBITDA for practices under $1 million, rising to 9x to 12x or more above $7 million, with add-on acquisitions at 5x to 9x. Where you land depends on size, surgeon depth, growth and facility ownership.
FOCUS also describes $3 million of EBITDA as a key threshold, where the buyer pool shifts from local add-on to platform-ready and multiples can rise by two to four turns. For a full breakdown, see our guide to plastic surgery practice valuation.
Who’s likely to buy your practice?
It depends on your size. TUSK Practice Sales says MSO partnerships suit practices with $2 million or more in revenue and that doctor-to-doctor sales are common below that (PR Newswire). Private equity groups target larger, multi-location practices, while aesthetics groups and hospitals fill specific niches.
For a detailed look at each buyer type, including named platforms, how MSO deals work and how to vet a buyer, read our guide to who buys plastic surgery practices. And for the step-by-step process, see our guide on how to sell a plastic surgery practice.
Looking to buy a plastic surgery practice?
If you’re a surgeon looking to buy, expect competition from private equity-backed platforms for larger practices. Your advantage is usually with smaller practices, where owners value continuity and a surgeon successor. Look for practices with a stable team, a transferable brand and an owner willing to stay through a transition.
Practical tips for surgeon buyers:
- Build relationships with retiring surgeons in your target area before they decide to sell
- Consider an associate position with a path to buy-in, which lets both sides test the fit
- Line up financing early, since healthcare lenders move slower than PE buyers
- Review patient retention risk carefully, because patients often follow the surgeon, not the practice
Frequently asked questions
How do I put my plastic surgery practice for sale?
Start by deciding what you’re selling, recasting your financials, reducing dependence on yourself and gathering compliance and contract records. Then work with an advisor to approach qualified buyers confidentially, under NDAs, and compare offers on total value. Starting a year or more ahead gives you time to fix issues that lower value.
Is plastic surgery consolidation still growing?
Yes. Physician Growth Partners counts ten or more PE-backed plastic surgery platforms, with six formed in one 24-month period, and says most practices remain independent. FOCUS Investment Banking reported a 440% increase in plastic surgery deal volume over the two years to 2024, and buyers expect continued activity.
What is the platform exit wave in plastic surgery?
It’s the period when private equity firms that bought plastic surgery platforms in recent years look to sell them. Private equity usually holds investments for several years, and FOCUS describes a five-to-seven-year hold in physician practice deals, so platforms formed in the early 2020s are approaching their exit window.
Should I sell before or after my platform’s buyer sells?
If you’re independent, a platform preparing to sell may pay well to add your practice, but your rollover equity would face a sale soon after. Joining a newer platform may mean a longer wait for a potentially larger second payday. Ask each buyer about its fund timeline before choosing.
Can I find plastic surgery practices for sale online?
Some small practices are listed on business-for-sale sites, but most plastic surgery practices sell privately through advisors and direct approaches. Sellers usually avoid public listings to protect confidentiality. Surgeon buyers do better by building relationships with owners nearing retirement and working with advisors who know which practices may be available.
What metrics do buyers review in plastic surgery practice management?
Consultation volume, conversion rates, case mix, revenue per procedure, marketing cost per new patient, non-surgical revenue, staff turnover and patient reviews. These show how well the practice runs without the owner. Clean, consistent reporting on these metrics supports a higher valuation and speeds up diligence.
Plastic surgery practice for sale: the bottom line
A plastic surgery practice for sale in 2026 enters a consolidating market with active buyers and a likely wave of platform sales ahead. Prepare early, understand where each buyer is in its own cycle, sell confidentially and choose the structure that fits your goals, not just the highest headline number.
| Considering a sale in the next few years? Get the Plastic Surgery Exit Report newsletter for quarterly market updates, or book a confidential conversation with the plastic surgery team at Olympic M&A. Disclosure: Plastic Surgery Exit Report is published in partnership with Olympic M&A, a healthcare M&A advisory firm. |
